Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 43Neoplasms 19Neoplasm Metastasis 17Rectal Neoplasms 12Colonic Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 5Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma 3Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Advanced Solid Tumors 2Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Solid Tumor, Adult 1Kidney Neoplasms 1Histiocytosis 1Gastrointestinal Neoplasms 1Exanthema 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Brain Neoplasms 1

Interventions

Prednisone 102enzalutamide 74Docetaxel 72Abiraterone Acetate 67Leuprolide 47acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 45abiraterone 37apalutamide 28Prednisolone 27bicalutamide 26Zoledronic Acid 24pembrolizumab 22Goserelin 22radium Ra 223 dichloride 21darolutamide 21Triptorelin Pamoate 17cabazitaxel 15Androgen Antagonists 15sipuleucel-T 13luprolide acetate gel depot 12Injections 12Dexamethasone 12olaparib 11gallium 68 PSMA-11 10Mitoxantrone 10Pluvicto 9Ipilimumab 9Dutasteride 9Cyclophosphamide 9relugolix 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Prostatic Neoplasms × Panitumumab × Clear all
NCT00425204 2008-09-15

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Amgen

Phase 2 Completed
31 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Colorectal Neoplasms

NCT00061126 2005-06-24

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Abgenix

Phase 2 Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡